
In Lannion, Brittany, Cristalens Industrie recently opened the doors of its manufacturing site to a high-level delegation led by Amaury de Saint-Quentin, Prefect of the Brittany Region, and Loïg Chesnais-Girard, President of the Brittany Region, accompanied by local representatives including Paul Le Bihan, Erven Léon, Alain Le Bouffant and Gervais Egault.
The visit focused on a strategic industrial project: the development of an innovative moulding process for intraocular lenses (IOLs) supported by the France 2030 investment plan.
France 2030 backing an innovative IOL moulding process
Cristalens Industrie is a French SME specialising in intraocular lenses used in cataract surgery. The company is currently developing a new full moulding process, injecting a liquid ophthalmic material between two shells to obtain a finished lens. This innovation is financed through a €500,000 repayable advance, granted under the regionalised Inno-Avenir PIA4 scheme within France 2030. The project spans 36 months (2024–2027), with funding released in two steps:
-
€350,000 at project start (January 2025)
-
€150,000 at the end of the development phase (September 2027)
The moulding project is designed to:
-
cut raw material consumption by around 50%
-
significantly increase manufacturing capacity, with up to 500,000 additional intraocular lenses per year
-
improve competitiveness on price-sensitive international markets, such as China and Latin America
In the ophthalmic industry, complete moulding of finished intraocular lenses is still managed by very few players, due to complex technical challenges: controlled filling of the shells, polymerisation, demoulding, and the development of a new material and specific lens design.
A French ophthalmic manufacturer with global reach
During the facility tour, the delegation discovered each step of the IOL manufacturing process in Lannion: from material preparation and clean-room production to inspection, polishing and final packaging.
Cristalens Industrie employs around 160 people and controls the entire value chain, from raw material production in Strasbourg to finished intraocular lens packaging. The company combines a strong presence in the French market with exports to over 50 countries, while maintaining 100% French manufacturing.
A pioneer in hydrophobic intraocular lenses, Cristalens is recognised for its patented technologies, including its premium SYMBIOSE lens, designed to provide continuous vision at all distances after cataract surgery.
With the support of France 2030 and the Brittany Region, this moulding project marks a key milestone in the company’s industrial roadmap and strengthens France’s position in ophthalmic medical devices and visual health innovation.
